-
1
Study shows CXL is effective for keratoconus across ethnic groups.
-
2
570 eyes analyzed with follow-up of 3 years.
-
3
>80% of eyes stabilized/improved post-treatment.
-
4
Baseline disease severity is a key determinant of CXL effectiveness.
-
5
Ethnicity and age do not significantly affect treatment outcomes.
-
6
CXL should be offered broadly, not delayed due to demographics.
Original Source(s)
Related Content
Introducing: Moorfields and UCL Centre for Eye Health
New London eye health centre named ahead of 2027 summer opening
April 17, 2026
-
2 min
Colonizing Corneal Healing
Genetically engineered ocular bacteria accelerates corneal wound healing by colonizing the eye and secreting interleukin-10
April 17, 2026
-
3 min
Unraveling Cataract’s Molecular Origins
UC Irvine research sheds new light on age-related cataract formation
April 17, 2026
-
3 min
